← Eichor
Study identifier: NCT05426720 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Risk Factors and Biomarkers for Post-tuberculosis Lung Damage

Condition: Pulmonary TB  ·  Sponsor: Peking University Third Hospital

PhaseN/A
Planned participants400
Who can joinMale, 25 Years to 60 Years
Healthy volunteersNo

About this study

This prospective study aims to determine the incidence of Post-tuberculosis lung damage (PTLD), examine trends in the changes in lung function, and investigate the impact of smoking and other factors on respiratory symptoms, lung function, and chest CT findings, which will aid in the development of prognostic and therapeutic strategies for PTLD.

This description comes directly from the study's public registry record.

Talk to the study team

Xiaoyan Gai, MD  ·  13522708870  ·  gxy81wfl79@163.com

Sun

Always discuss trial participation with your own doctor first.

Locations (2)

Peking University Third HospitalBeijing, ChinaRecruiting
Beijing Geriatric HospitalBeijing, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05426720